Triple-negative (negative for estrogen receptor, progesterone receptor, and human epithelial receptor 2 (HER2) gene amplification) breast cancer (TNBC) is an aggressively metastatic subtype with a disproportionately high rate of TP53 mutation compared to other breast cancer subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.